The FDA has asked five drug manufacturers to voluntarily recall several lots of extended-release metformin after agency lab testing revealed unacceptable levels of the nitrosamine impurity N ...

Metformin is the latest medication to be recalled due to concerns about a contaminant that may cause cancer. This time the contaminant is NDMA, which doesn’t stand for North Dakota-Massachusetts ...

The drug, metformin, is used to control high blood sugar in type-2 diabetes patients. The FDA said it found the impurity in certain extended-release versions of the drug, not immediate-release ...

Were Metformin Drugs Recalled Due to Cancer-Causing Compound? The FDA recommends that patients prescribed Metformin continue taking the drug until consulting with their health care provider.

The FDA advises voluntary recall of extended-release metformin made by five manufacturers after NDMA contamination found in some batches.

The FDA has announced the recall of one brand of a popular type 2 diabetes drug, metformin, over a potentially cancer-causing impurity. Viona Pharmaceuticals, Inc. is voluntarily recalling 23 lots ...

The FDA has asked five drugmakers to voluntarily recall their metformin products after it found unacceptable levels of a carcinogen in the drug, The Wall Street Journal reported.

After the FDA identified a likely carcinogen in samples of the broadly used diabetes med metformin, recalls appeared likely. Now it's official. The FDA said Thursday it had asked five metformin ...

Several companies have initiated recalls of metformin extended-release tablets due to the possibility of unacceptable levels of N-Nitrosodimethylamine, a probable human carcinogen.

Indian pharmaceutical company Marksans Pharma Limited is recalling Metformin Hydrochloride Extended-Release Tablets because its levels of NDMA, a “probable human carcinogen,” were higher than ...

An online pharmacy is calling for U.S. regulators to recall batches of the metformin diabetes medicine after tests found a possible carcinogen.

US health regulators are telling five drugmakers to recall their versions of a widely used diabetes medication after laboratory tests found elevated levels of a contaminant linked to cancer. The Fo… ...